Results 211 to 220 of about 484,364 (380)
Clinical use of placebo treatments may undermine the trust of patients: a response to Gold and ...
Pekka Louhiala Harri Hemilä
core
Influence of hospitalization and placebo therapy on blood pressure and sympathetic function in essential hypertension. [PDF]
V. Hossmann+2 more
openalex +1 more source
Objective Fecal microbiota transplantation (FMT) holds promises as a beneficial supplement to methotrexate in patients with psoriatic arthritis (PsA). We therefore investigated how gut bacterial signatures in patients and donor strain engraftment associated with long‐term response to FMT.
Panpan Qin+7 more
wiley +1 more source
Open-Label-Placebos can reduce pain, but not indigestion during gluten challenge in chronic pain patients. [PDF]
Paschke-Dahl L, Klinger R.
europepmc +1 more source
Terfenadine and placebo compared in the treatment of chronic idiopathic urticaria: a randomised double‐blind study. [PDF]
Jamie Ferguson+2 more
openalex +1 more source
A phase 2 trial of hydroxychloroquine in individuals at risk for rheumatoid arthritis
Background Individuals with serum elevations of anti‐cyclic citrullinated peptide (anti‐CCP) antibodies are at increased risk for future rheumatoid arthritis (RA). No pharmacologic interventions have been approved for the prevention of RA in such ‘at‐risk’ individuals. However, hydroxychloroquine (HCQ) is used without supporting clinical trial evidence.
Kevin D. Deane+33 more
wiley +1 more source
A double-crossover trial comparing the effects of topical carteolol and placebo on intraocular pressure. [PDF]
G. R. Duff, P. A. Graham
openalex +1 more source
Background Gout due to the formation of monosodium urate (MSU) crystals and calcium pyrophosphate (CPP) deposition disease are two major types of microcrystalline pathologies in adults. They are responsible for recurrent flares that rely on interleukin (IL)‐1β via activation of the NLRP3 inflammasome.
Chinh Nghia Pham+15 more
wiley +1 more source